For all diseases, prevalence has been carefully studied. In the "classic" paradigm, the prevalence of different diseases has usually been studied separately. Accumulating evidences have shown that diseases can be "correlated". The joint analysis of prevalence of multiple diseases can provide important insights beyond individual-disease analysis, however, has not been well conducted. In this study, we take advantage of the uniquely valuable Taiwan National Health Insurance Research Database (NHIRD), and conduct a pan-disease analysis of period prevalence trend. The goal is to identify clusters within which diseases share similar period prevalence trends. For this purpose, a novel penalization pursuit approach is developed, which has an intuitive formulation and satisfactory properties. In data analysis, the period prevalence values are computed using records on close to 1 million subjects and 14 years of observation. For 405 diseases, 35 nontrivial clusters (with sizes larger than one) and 27 trivial clusters (with sizes one) are identified. The results differ significantly from those of the alternatives. A closer examination suggests that the clustering results have sound interpretations. This study is the first to conduct a pan-disease clustering analysis of prevalence trend using the uniquely valuable NHIRD data and can have important value in multiple aspects.
Introduction
For most if not all diseases, prevalence, both its specific values and temporal and spatial trends, have been well examined. The analysis of disease prevalence has important implications for the allocation and planning of medical resources, identification of risk factors, development of interventions, and other purposes. Accordingly, statistical methods have been extensively developed for analyzing disease prevalence, ranging from simple summary statistics to advanced nonparametric fitting. We refer to the literature for detailed discussions on clinical interpretation and application (Rothman, 2012) and statistical methodology (Keiding, 1991) .
Under the "classic" paradigm, prevalence, as well as other outcomes, have been studied for each disease separately. Accumulating evidences have shown that diseases can be "correlated".
Examples include the positive correlations in the occurrence, prognosis, and other outcomes of breast cancer and ovarian cancer, which are attributable to the shared molecular risk factors and hormone-related treatment regimens. Another example is the positive correlations in the occurrence and other outcomes of asthma, lung cancer, and other respiratory diseases, which are attributable to the shared environmental and genetic risk factors. Recent studies have shown that the joint analysis of multiple diseases can lead to important insights not shared by its individual-diseasebased counterpart (Rzhetsky et al., 2007; Goh et al., 2007) .
For prevalence, the outcome of interest in this study, the joint analysis of multiple diseases has been conducted. For example, a prospective observational study conducted in the U.S. focuses on the prevalence of chest pain and acute myocardial infarction (MI) and suggests that patients without chest pain on presentation represent a large segment of the MI population and are at an increased risk for delays in seeking medical attention (Canto et al., 2000) . Another example is the cancer metastasis networks, which have been established based on clinical data (Chen et al., 2009 ). Despite several interesting findings, our literature review suggests that the existing joint analyses of prevalence have the following limitations. Some studies focus on a small number of pre-selected diseases (for example, heart diseases only) and do not have a "global" perspective. The interconnections in prevalence among diseases are still largely unknown, and it is desirable to conduct "unguided learning" and identify new interconnections. Some studies conduct cross-sectional analysis. It has been recognized that temporal and spatial variations can have more important implications than static values. There are also studies with limitations in quantitative analysis by adopting (overly) simple statistical methods. In the single-disease analysis of prevalence (and other outcomes), it has been shown that sophisticated statistical methods, for example nonparametric modeling, have the power to produce important findings missed by simple statistics. Some other studies are based on limited data, for example, collected from a small number of hospitals and communities. Such data, although interesting to a certain extent, have a selection bias problem and cannot describe the more valuable population-level properties. Our ultimate goal is to understand disease interconnections in terms of prevalence temporal trend. In this article, the specific goal is to identify clusters, within which diseases share similar prevalence temporal trends. To fix ideas, a symbolic presentation of our motivation and the proposed analysis is provided in Figure 1 . In the left panel, we show the temporal trends of period prevalence for ten diseases, which may seem unstructured. However, if we ignore the absolute values and move the prevalence curves vertically, as shown in the right panel, the ten diseases clearly form three clusters, with those in the same cluster having similar trends.
In the literature, much attention has been paid to the magnitude of prevalence. In contrast, research on the shared temporal trends of diseases' prevalence has been extremely rare. However, it can have important implications beyond that on absolute magnitude. Specifically, the absolute magnitude of a disease' prevalence can be largely attributable to time-independent risk factors, such as genetic predisposition. In contrast, the variation of prevalence over time can be mostly attributable to time-varying factors, such as weather conditions, air/water quality, development of prevention programs, and others. If two diseases share similar temporal trends of prevalence, no matter their absolute magnitudes are close or not, it is sensible to conjecture that they share time-dependent risk factors and/or are affected by similar prevention programs. Such risk factors and prevention programs are more actionable than, for example, genetic predisposition. As such, the proposed analysis of shared temporal trends may have important practical implications not possessed by that on absolute magnitude. This study can contribute beyond the existing literature in the following aspects. The proposed study objective, identification of diseases with shared prevalence trends via clustering analysis, innovatively differs from those in the existing studies, which usually focus on the static, absolute magnitudes. A large number of diseases are simultaneously analyzed. Avoiding pre-selection can lead to discoveries beyond existing knowledge. The pan-disease analysis can facilitate a more "global" description of disease prevalence. The analyzed NHIRD data is uniquely valuable with a huge sample size and virtually no selection bias, which can lead to more credible and unbiased findings. In addition, a novel analysis method is implemented, which has a sound statistical basis and numerically outperforms multiple existing alternatives. It can have broad applications far beyond this study and thus independent value. Overall, this study may have significant biomedical as well as statistical merits.
The National Health Insurance Research Database (NHIRD)
Taiwan launched the single-payer National Health Insurance (NHI) program on March 1st, 1995.
As of 2014, 99.9% of Taiwan's population were enrolled. With the high cost of healthcare that is uninsured or covered by commercial insurance, almost all hospital/clinic-based healthcare has been going through NHI. Under NHI, hospitals and clinics are obligated to report detailed diagnosis (and treatment) data. Such data have been collected under the National Health Insurance Research Database (NHIRD) project (http://nhird.nhri.org.tw/en/). The NHI data have unique advantages, especially including unbiasedness (virtually the whole population is covered), comprehensiveness (information is available on all diagnosis/treatment episodes), and unity (all data collection follows the same protocol), and have served as the basis of a large number of epidemiological, clinical, health economic, and management studies (close to 400 publications on pubmed).
The proposed analysis may not be feasible with other databases. Specifically, hospital and community-based databases suffer from small sample sizes and a potential selection bias; Databases such as Medicare and Medicaid do not cover the general population and hence also have a selection bias problem; And those based on specific commercial insurance schemes are very difficult to access and suffer from a similar selection bias problem.
There are multiple ways of defining prevalence. In this study, we focus on period prevalence, which is defined as the percentage of the population with a certain disease within a fixed period of time (in our analysis, one year). The health care and insurance system in Taiwan is among the most developed, and undertreatment (presence of illness conditions that are not treated), although may exist, is expected to be rare. As such, the number of people treated with a certain disease (within one year) can provide a reasonable approximation to the number of people with this disease.
The analyzed data are extracted from NHIRD and contain records on 1 million randomly selected subjects (about 4.3% of the Taiwan population) for the period of 2000-2013. Disease diagnosis (and hence period prevalence) information is extracted from both outpatient and inpatient With the large number of observations, the accuracy of analysis may far exceed many peer studies.
ICD-9-CM contains more than 14,000 diseases, and directly using this code leads to very few diagnoses for many diseases. We apply the Phenome-Wide Association Study (PheWAS) vocabulary approach (Wei et al., 2017) and group the 14,000 ICD-9-CM diseases into 1,723 disease codes.
It is realized that even with a huge sample size, the prevalence values for rare diseases may not be reliably estimated. As such, we remove diseases with extremely low prevalence. To make the analysis "more interesting", we further focus on two types of diseases. The first type of diseases are those with high prevalence and/or high mortality, for example upper respiratory tract infections, disease of the circulatory system, cancers, and others. Such diseases have significant public health implications. The second type of diseases are those with high clinical significance, for example, those with no effective treatment or clear causes, such as some cancers (e.g., melanoma), some diseases of the blood and blood-forming organs (e.g., autoimmune hemolytic anemias), congenital coagulation defects, and others.
A total of 405 diseases are included in the final analysis. This number is considerably larger than those in the existing studies. It is noted that the proposed analysis can be straightforwardly extended to all diseases. However, as for each disease the number of prevalence measurements (number of years) is rather limited, and as each disease is allowed to have its unique prevalence trend (details below), the analysis may become less reliable with a larger number of diseases.
Among the analyzed diseases, those with the highest prevalence include acute upper respiratory infections of multiple or unspecified sites, dental caries, acute bronchitis and bronchiolitis, acute sinusitis and others, all of which have been extensively studied in the literature. Those with the highest temporal variations include acute upper respiratory infections of multiple or unspecified sites, noninfectious gastroenteritis, gingivitis, essential hypertension, and others. Multiple different types of trends are observed, including virtually flat (for example, Takayasu's disease), increasing (for example, uterine leiomyoma), decreasing (for example, ulcerative colitis (chronic)), "U" shape (decreasing and then increasing; for example, benign neoplasm of thyroid glands), reversed U shape (for example, other diseases of the teeth and supporting structures), and others. More details are presented in Section 4 as well as available from the authors.
Methods
As can be partly seen from Figure 1 , the proposed analysis basically poses a functional clustering (classification) problem. In the literature, multiple approaches have been developed. Examples include the functional K-means and those alike, which, under certain data/model assumptions, compute the 2 distance between functions, and then conduct clustering in a similar way as for scalars. There are also methods that are more model-based. They assume that the observed functions (or their values at discrete time points) are generated from some underlying parametric/nonparametric functions, which are then recovered for the purpose of clustering. For relevant discussions, we refer to Jacques & Preda (2014) , Abraham et al.(2003) , and Peng & Müller (2008) .
A penalization pursuit approach
In "simple" clustering analysis with finite-dimensional random variables, it has been observed that no clustering approach is dominatingly better. It is thus always of interest to develop alternative methods. This can be especially true for functional clustering, considering the scarcity of avail-able methods. In addition, as to be described below, the proposed method has multiple unique advantages.
In the analysis of NHIRD data, we have 14 period prevalence values (one per year) for each of the 405 diseases. Generically, assume that for each disease, the observed prevalence values are realizations of an unknown curve in L 2 [a, b] , where [a, b] is a finite interval. Denote N as the number of diseases (sample size), y 1 (·), ..., y N (·) as the N prevalence curves, and t 1 , ..., t T ∈ [a, b] as the T time points of observation. As described above, the proposed analysis focuses on trend as opposed to absolute magnitude. As such, prior to analysis, y i 's are normalized to have "means" zero, and with a slight abuse of notations, we still use y i 's to denote the normalized values. Following a popular strategy in functional analysis, we conduct basis expansion. Specifically, consider
Here {φ l , l = 1, . . . , K} is a set of K basis functions in L 2 [a, b] , and β il 's are the unknown regression coefficients. In the literature, extensive works are available on choosing the form and number of basis functions and will not be reiterated here. Note that for the present problem, the assumption of independent errors can be sensible.
  , and β i = (β i1 , ..., β iK ) . We consider the estimate
where λ > 0 is a data-dependent tuning parameter and w ij 's are data-dependent weights. In our numerical study, we set w ij = β ols i −β ols j −1 withβ ols i = argmin Y i − Bβ i 2 . Diseases i and j are concluded as in the same cluster ifβ i =β j .
Rationale Here we adopt the popular basis expansion estimation approach. The proposed analysis can generate functional clusters as well as estimated prevalence curves for these clusters as a "byproduct", which may facilitate interpretation and other purposes. The proposed approach innovatively "transforms" clustering into a penalized pursuit problem, and relies on penalization to data-dependently determine the number of clusters, clustering structure, etc. This strategy allows sufficient flexibility. For example, there is no assumption/constraint on the sizes of clusters, and it is possible that a disease forms a cluster of its own. The strategy of clustering via penalization is pioneered in recent studies (Shen & Huang , 2010) . Significantly advancing from the literature, the proposed analysis is conducted on a large number of functions in the disease prevalence analysis.
As each curve is represented by multiple basis functions and their regression coefficients, group penalization is needed. Here the group Lasso is adopted and can be replaced by other group
penalties. An adaptive penalization is adopted to improve performance. There are extensive discussions in the literature on group and adaptive penalization and will not be reiterated here.
In "classic" nonparametric estimation, penalty is usually imposed on β i 's. The present analysis goal differs from that in the existing studies, and the differences β i − β j 's are penalized to achieve clustering. When desirable, additional penalties can be imposed on β i 's. In modeling, it is assumed that σ i 's may vary across diseases. It is possible to estimate σ i 's from OLS and construct a variance-weighted loss function. However, as a large number of variances need to be estimated, the unweighted objective function may be more stable and performs well as long as the variances are not too heterogeneous.
Computation
To simplify notation, consider the unweighted optimization
As in (7) the weights are predetermined, its optimization can be conducted in exactly the same manner. The above optimization can be written as
Lagrangian is given by:
For optimization, we adopt the ADMM technique, which is iterative with the following updates at iteration m + 1:
Taking derivative w.r.t β i , we obtain
With this equation, we can have
Taking derivative w.r.t z ij and equating to 0 yield
Overall, with a fixed tuning parameter λ, the ADMM algorithm uses 0 or the OLS estimate as the starting value and iterates as described above until the difference between two consecutive estimates is small enough (such that convergence can be concluded).
Tuning parameter selection λ controls the degree of shrinkage and hence the number of clusters and clustering structure. In the extreme case with λ = ∞, all diseases are clustered together; and λ = 0 leads to one disease per cluster.
It is noted that, different from most of the existing functional studies, the curves are not all iid realizations of the same underlying distribution. Potentially, a curve can be unique and form and B. We propose selecting λ that minimizes
This has been partly motivated by the split-half tuning parameter selection for time series and other data, is expected to behave reasonably if the curves are relatively "stable", and observed to have satisfactory numerical performance. In practice, we conduct a grid search for the optimal λ.
Simulation
Simulation is conducted to gain insights into the practical performance of the proposed method.
In the first set of simulation, functions are generated as the cluster-specific mean functions plus random errors. Observations are then made for each function at 20 equally spaced time points with t 1 = 0.1, . . . , t 20 = 2. For all i and j, ij ∼ N (0, σ).
A total of eight clusters are defined as follows. Cluster 1 Let ψ j (t), j = 1, 2 be the monomial basis. y i (t j ) = 2 − ψ 1 (t j ) − 1.5ψ 2 (t j ) + ij . Cluster 2 Let ψ j (t), j = 1, 2 be the monomial basis. For the sizes of clusters, we consider two scenarios: Scenario 1 has equal sizes with n 1 = . . . = n 8 = 12, and Scenario 2 has unequal sizes with n 1 = 11, n 2 = 17, n 3 = 15, n 4 = 9, n 5 = 11, n 6 = 13, n 7 = 14, n 8 = 10. In addition, we also consider different random error levels with σ = 0.1, 0.2, 0.3, 0.4. In our analysis, clustering is of the highest interest. To evaluate clustering accuracy, consider the N × N matrix A, whose (i, j)th element is 1 if curves i and j belong to the same cluster and 0 otherwise. Denote the estimate of A asÂ. We define clustering Error = i<j |A(i, j) −Â(i, j)|, which is the unnormalized error count. To better gauge performance of the proposed method, we also consider six relevant competitors.
[Alt.1] This method is proposed by Abraham et al. (2003) . It first fits data using B-splines (for each curve separately) and then conducts clustering of the estimated B-spline coefficients using the Bouveyron et al. (2015) and based on mixture modeling. It takes functions as input. As such, we implement a smoothing method to obtain functions passing through the observed discretized points (more details can be found in Ramsay & Silverman (2005) ). This method is implemented using the R package funFEM.
Specifically, we specify the range of the number of clusters to be from 2 to 10 and select the "all" option, which allows for the implementation of all the 12 models proposed in this work and selects the optimal one. [Alt.4] This is a curve clustering method using the functional random variable density approximation and proposed in Jacques & Preda (2013) . It is realized using the R package
Funclustering. We set the number of clusters as eight, which may lead to favorable performance.
[Alt.5] The FClust approach, which can be realized using the R package fdapace, conducts functional clustering and identification of data substructures for longitudinal and other functional data. In the original development, data-dependent determination of the number of clusters is not proposed.
Here we consider two cases. The first is to set the number of clusters as the true. The second is to consider the number of clusters as true+1, which may serve as a sensitivity analysis. [Alt.6] The funHDDC method, which can be realized using the R package funHDDC, conducts model-based clustering and identification of functional subspaces. It is originally developed for time series data.
For all seven methods, clustering errors are computed based on 100 replicates and presented in Table 1 . The second simulation is built on the first one. Here we set σ = 0.3 and consider: Scenario 3 with n 2 = 25, n 4 = 25, n 5 = 5, n 7 = 25, and n 1 = n 3 = n 6 = n 8 = 0, and Scenario 4 with n 1 = 25, n 3 = 5, n 6 = 25, n 8 = 25, and n 2 = n 4 = n 5 = n 7 = 0. Here there are four clusters, and the cluster sizes are highly unbalanced. Here we also examine performance of the proposed and alternative methods as T , the number of observation points, increases. Table 2 suggests that as T increases, performance of the proposed method improves fast and significantly. When T = 40 or larger, the proposed approach virtually has no clustering error.
Performance of Alt.2 also improves. This is reasonable, as loosely speaking, it shares a similar spirit as the proposed: both of them can be viewed as a certain form of thresholding. Performance of the other alternatives may be "less sensitive" to T . A "counterintuitive" observation is that performance of some alternatives may get slightly worse when T is large, which can be caused by the overly wiggly estimated functions. It is also observed that with Alt.5, if the number of clusters is set as true, performance can be extremely well. However, it becomes less satisfactory when the number of clusters is off.
Analysis of NHIRD data
Data described in Section 2 are analyzed using the proposed approach. A total of 35 nontrivial clusters (with sizes larger than one) are identified. In addition, there are also 27 diseases forming their own individual clusters. For the identified clusters, we plot the observed period prevalence curves (without normalization) in Figure 2 . Here different colors are used to represent different prevalence levels. The detailed disease information is provided in Appendix II. A total of 201 diseases in the first 14 clusters in general have increasing trends. However, the shapes show considerable differences. As discussed in the literature, disease prevalence is affected by both genetic and non-genetic factors. With most if not all investigated diseases being genetically highly stable, the observed variations in prevalence are mostly attributable to non-genetic factors.
For example, environmental factors, which usually vary over time, have been suggested as causal for the increase in prevalence of certain diseases. Factors identified in the literature include worse air quality, unhealthier dietary behaviors, stressful working conditions, and others. In addition, the development of more effective diagnostic tools may also contribute to the observed increasing prevalence (Abdollah et al., 2013) . A closer examination of Table 4 Registry data, a database independent of NHIRD, suggests that oral cancer (OC) is one of the fastest growing malignancies in Taiwan, which is largely attributable to certain unhealthy lifestyle factors, including tobacco smoking, alcohol drinking, and betel quids chewing (Chiang et al., 2010) .
Also included in clusters 1-14 and showing increasing prevalence include diseases such as Alzheimer's disease, hypertensive heart disease, chronic kidney disease, HIV infection, and others. They all have been observed to have increasing prevalence in the literature. The main goal of the proposed analysis is to identify clusters of diseases, which may be caused by shared risk factors. Examining clusters 1-14 suggests that there are sound interpretations for certain diseases being clustered together. For example, cluster 9 includes human papillomavirus (HPV) associated malignant neoplasm of uterus, cancer of tongue/nasopharynx, acute/prostatitis as well as orchitis and epididymitis. They share the same risk factor HPV (Bonneau et al., 2014) . In cluster 11, hyperglyceridemia and disorder of lipoid metabolism are confirmed risk factors of myocardial infarction and hypertension (Austin et al., 1998) . The latter can lead to myocardial infarction, hypertensive chronic kidney disease, and cerebrovascular disease (Kario et al., 2004) . In addition, acute renal failure is another risk factor of chronic kidney disease (Lo et al., 2009) . As core symptoms of depression (Nutt et al., 2008) , sleep disorders, depression, and major depressive disorder are grouped together (cluster 12).
Our clustering analysis also identifies diseases sharing similar prevalence trends but do not yet have solid support from the literature. For example, acquired coagulation factor deficiency and renal osteodystrophy have very similar prevalence trends, but there is a lack of evidence for their connections. This can be caused by chance, connections with other diseases that are connected, as well as unidentified shared risk factors. More exploration is needed in the future.
In the next 7 clusters (15-21), a total of 55 diseases showing various decreasing prevalence trends.
The decrease in disease prevalence can be caused by prevention interventions (lowering incidence), improvements in treatment and care, as well as disease-modifying interventions (preventing or slowing progression). Many of the decreasing trends observed in Figure 2 have also been reported in the literature for Taiwan as well as other countries/regions, and plausible causes have been suggested.
For example, a decreasing trend of tuberculosis (TB) has been reported in most countries over the past decade, which is largely attributable to national tuberculosis control programs (Ohmori et al., 2002) . As above, many of the observed co-clusterings of diseases also have sound interpretations. For example, CNS infection/poliomyelitis and encephalitis are both included in cluster 15.
CNS infection is a major risk factor of encephalitis (Annegers et al., 1988) . In cluster 18, acute rheumatic heart disease often leads to heart valve disorders and can cause ischemic heart disease as well as acute pulmonary heart disease when the condition deteriorates (Young et al., 2006) . As for the increasing trends, there are also new discoveries that warrant additional investigation. Clustering is also conducted using the six alternative approaches described in simulation. The Table 3 . It is observed that the results from the proposed clustering are relatively similar to those of Alt.1, Alt.2, and Alt.5, but quite different from the other three approaches.
The six alternatives generate results from relatively similar (e.g., Alt.3 and Alt.6) to significantly different (e.g., Alt.2 and Alt.3). With practical data, it can be difficult to determine which clustering is more accurate. The better simulation performance and sound interpretations can provide some confidence to the proposed clustering.
Discussion
In the analysis of NHIRD and other data alike, the prevalence of various diseases is of great importance. Advancing from the literature, this study has taken a novel different strategy and focused on the similarity in diseases' prevalence trends under the functional clustering framework.
Another highlight is that a pan-disease approach has been taken, under which a total of 405 diseases have been analyzed. This study is the first of its kind and, as described in Section 1, can have important practical implications. The results can be informative to the Taiwan population and health care/insurance system as well as other countries/regions and populations. A functional clustering method has been proposed using the innovative penalized pursuit technique. It has been
shown to have competitive numerical performance and satisfactory statistical properties. It can have broad applications in functional data analysis far beyond this study.
This study can be potentially extended in multiple directions. Disease prevalence depends on multiple factors and varies across regions and populations. It can be of interest to conduct similar analysis for other regions/populations. It is also noted that this can be very challenging with the difficulty in obtaining data comparable to the NHIRD. The shared temporal trends of disease prevalence can be caused by multiple factors. Some examples of plausible interpretations have been provided. However, we defer to future research to more systematically and quantitatively quantify the causes of similar trends. It is also of interest to apply the proposed method to other functional data problems and conduct more comparisons.
Appendix I: Statistical properties
In this study, we have been focused on methodological development and data analysis. To provide more insight into the proposed method, we also briefly examine its statistical properties.
For the convenience of notation, we rewrite the objective function as
For this "new" objective function, we make the following assumptions:
It is noted that for lucidity, we have made assumptions directly on the w ij 's, which can be obtained from the estimation properties of the underlying functions. For example, under Assumption A1
and certain regularity conditions, Corollary 2.1 of He & Shao (2010) 
Note that B B T converges to the identity matrix. For each i, the first term is quadratic in u i and O(K); the second term is linear in u i with its coefficient being O p (K); and finally from assumption A2, the last term is O p (K) and linear in u i . Thus, with a properly chosen ∆, the theorem can be proved.
Theorem 2. (Clustering consistency) Consider any
Proof. Consider a cluster including curves y 1 , y 2 , that is, β 1 = β 2 . Below we show that P (β 1 = β 2 ) = 0 by contradiction.
Suppose thatβ 1 =β 2 . Differentiating the objective function Q(β) with respect to β 1 leads to the following normal equation:
The first, second, and last terms are O p (1), and the third term dominates from Assumption A3, leading to a contradiction. Thus, P (β i =β 2 ) = 1. 
